Detection of Pseudomonas aeruginosa producing metallo-β-lactamases in a large centralized laboratory

Detection of Pseudomonas aeruginosa producing metallo-β-lactamases in a large centralized laboratory
复制标题

DOI:
10.1128/jcm.43.7.3129-3135.2005
复制
发表时间:
2005-07-01
影响因子:
9.4
通讯作者:
Church, DL
Church, DL
中科院分区:
医学2区
文献类型:
--
作者:
Pitout, JDD;Gregson, DB;Church, DL

文献摘要

被引文献

相似文献

金属β-内酰胺酶(MBL)已越来越多地从世界各地的临床分离株中被认识到,但这些菌株的实验室检测并没有很好地定义。我们报告了一项研究,开发了一种EDTA纸片筛选试验和一种分子诊断试验来检测产生MBL的铜绿假单胞菌。使用NCCLS盘法,在单独使用亚胺培南(IPM)和美罗培南(MEM)盘以及与930 μ g EDTA组合的测试中测定抑制区直径。将该测试与MBL Etest进行比较。双重PCR检测显示100%的灵敏度和特异性检测MBL生产的对照菌株。在2002年至2004年从卡尔加里卫生区分离的241株IPM不敏感铜绿假单胞菌临床菌株中,110/241(46%)使用表型方法为MBL阳性,而107/241(45%)为MBL基因PCR阳性:103/241(43%)为bla(Vim),4/241(2%)为bla(IMP)。使用MEM的EDTA纸片筛选试验显示,检测对照和临床菌株中MBL的灵敏度为100%,特异性为97%。EDTA纸片筛选试验易于执行和解释,可以很容易地引入临床实验室的工作流程。我们建议使用EDTA纸片筛选试验对所有IPM不敏感的铜绿假单胞菌分离株进行MBL生产的常规筛选,并在区域实验室进行PCR确认。
Metallo-beta-lactamases (MBLs) have been increasingly recognized from clinical isolates worldwide, but the laboratory detection of these strains is not well defined. We report a study that developed an EDTA disk screen test and a molecular diagnostic assay for the detection of MBL-producing Pseudomonas aeruginosa. Using NCCLS disk methodology, inhibition zone diameters were determined in tests with imipenem (IPM) and meropenem (MEM) disks alone and in combination with 930 mu g of EDTA. This test was compared with the MBL Etest. The duplex PCR assay showed 100% sensitivity and specificity for detecting MBL-producing control strains. Of the 241 clinical strains of IPM-nonsusceptible P. aeruginosa from the Calgary Health Region isolated from 2002 to 2004, 110/241 (46%) were MBL positive using phenotypic methods while 107/241 (45%) were PCR positive for MBL genes: 103/241 (43%) for bla(VIM) and 4/241 (2%) for bla(IMP). The EDTA disk screen test using MEM showed 100% sensitivity and 97% specificity for detecting MBLs in control and clinical strains. The EDTA disk screen test is simple to perform and to interpret and can easily be introduced into the workflow of a clinical laboratory. We recommend that all IPM-nonsusceptible P. aeruginosa isolates be routinely screened for MBL production using the EDTA disk screen test and that PCR confirmation be performed at a regional laboratory.